Salazar E L, García M O, Avila A
Unidad de Investigación Médica en Biología de la Reproducción, con sede en el Hospital de Gineco-Obstetricia Luis Castelazo Ayala, IMSS, México, DF.
Ginecol Obstet Mex. 1998 Jul;66:263-6.
Between January and November 1992, forty eight women with benign disorders of the breast were studied and compared with one hundred fifty two patients with malignant disease of the breast. The content of alkaline phosphatase (ALP) levels was measured in the serum of premenopausal and postmenopausal patients. In all of them clinical history was taken, weight size and corporal mass index (CMI) (weight/size2). When the patients were grouped according to type of breast lesions, it appeared that plasmatic ALP levels, were higher in the groups with infiltrating carcinoma than in the women with benign disorders of the breast. The physiological status of the enzyme in this study, relate probably the activity of the tissue in either benign or malignant tissue, through fibroadenoma had less activity than adenocarcinoma. Status ALP (> or = 90 UI/L), CMI, menstrual state and histological type were compared. We found a significant correlation between these parameters.
1992年1月至11月期间,对48例患有乳腺良性疾病的女性进行了研究,并与152例患有乳腺恶性疾病的患者进行了比较。测量了绝经前和绝经后患者血清中碱性磷酸酶(ALP)水平的含量。对所有患者都进行了临床病史采集、体重、体型和体质指数(CMI)(体重/身高²)的测量。当根据乳腺病变类型对患者进行分组时,发现浸润性癌组的血浆ALP水平高于乳腺良性疾病组的女性。本研究中该酶的生理状态可能与良性或恶性组织中的组织活性有关,通过纤维腺瘤的活性低于腺癌。比较了ALP状态(≥90 UI/L)、CMI、月经状态和组织学类型。我们发现这些参数之间存在显著相关性。